EMEA-001065-PIP01-10
Key facts
Invented name |
Angiox
|
Active substance |
Bivalirudin
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0110/2012
|
PIP number |
EMEA-001065-PIP01-10
|
Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
The Medicines Company UK Limited
|
Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|